在心房患者的并发症和药物模式:与不良临床结果的关联
Dilek Celik1, Cheima Amrouch2,3, Søren Paaske Johnsen4
1Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131, Padua, Italy. dilek.celik@unipd.it.
Internal and emergency medicine
|July 17, 2025
概括
管理心房动 (AF) 需要了解患者的个人资料. 在AF患者中神经认知和精神病学模式增加了诸如血栓栓塞和严重出血等不良事件的风险.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 药理学 药理学是指药理学的学科.
背景情况:
- 在患有多种并发症和复杂药物治疗方案的患者中管理心房动 (AF) 存在重大挑战.
- 识别不同的患者个人资料对于个性化风险评估和管理策略至关重要.
研究的目的:
- 根据并发症和药物组合,确定心房的患者概况.
- 探索这些已识别的个人资料与AF患者不良结果的风险之间的关联.
主要方法:
- 隐性类分析用于确定633名AF患者的并发症和药物治疗模式.
- 考克斯回归分析评估了与血栓栓塞,严重出血,跌倒和死亡的关联.
- 在意大利一家抗凝血剂门诊所中,患者的平均随访时间为24.2个月.
主要成果:
- 确定了四种不同的AF患者概况:非特异性,糖尿病和肝脏,神经认知和精神病,肌肉骨,免疫和皮肤病.
- 神经认知和精神病学模式显示,与非特定模式相比,复合结果,血栓栓塞和严重出血的风险明显更高.
- 肌肉骨,免疫学和皮肤学模式与严重出血的风险增加有关,特别是在没有癌症的患者中.
结论:
- 在心房的特定患者简介与不良结果的差异性风险有关.
- 由于风险增加,抗凝血AF患者的神经认知和精神病学概况需要特别注意.
- 整体管理策略对于优化复杂的AF患者群体的护理至关重要.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
168
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
861
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
861
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
47
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
47
Dysrhythmias VI: Management of Dysrhythmias
110
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
110
Disturbances in Heart Rhythm
1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
130
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
130


